Table. 2.

Table 2 Biomedical activity and application of glycerolipids

Subclass	Name	Activity	Medical application	Ref.
Monoacylglycerol	Monocaprylate	Formation of transient or permanent pores in the membrane	Antimicrobial	Hyldgaard et al., 2012
	MonolaurinMoncaprin	Bactericidal activity against H. pylori	Infectious disease	Bergsson et al., 2002
	Monoolein	Antimicrobial activity against S. aureus and E. coli	Antimicrobial	Jumina et al., 2019
	MAG-DHA	Downregulation of NF-kB and upregulation of PTEN	Non-small cell lung cancer	Morin and Fortin, 2017
Diacylglycerol	Monogalactosyl diacylglycerol	Inhibition of CD31 positive tumor blood vessel growth.	Colon cancer	Maeda et al., 2013
	1,3-Diacylglycerol	Increasing oxidation of fatty acid and suppressing chylomicron formation	Obesity and insulin resistance	Saito et al., 2007
Triacylglycerol	Medium-chain triglyceride	Suppression of IL-6, iNOS, cyclooxygenase-2 and IL-10 and activation of NF-kB and p38 MAPK pathways	Insulin resistance	Geng et al., 2016
	Medium-chain triglyceride	Metabolized to ketone bodies to the brain	Neurological and metabolic disorders	Augustin et al., 2018b
	Tricaprilin (AC-1202)	Reducing oxidative damage and improvement of respiration rate in brain	Alzheimer’s disease	Henderson et al., 2009

Biomolecules & Therapeutics 2021;29:465~482 https://doi.org/10.4062/biomolther.2021.107

© Biomolecules & Therapeutics